Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by Introgen Therapeutics.
Recruitment status was  Recruiting
Study NCT00116363   Information provided by Introgen Therapeutics

First Received on June 28, 2005.   Last Updated on March 28, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malignant Melanoma
Neoplasm Metastasis
Additional conditions recognized in this trial
Melanoma
Neoplasms
More general conditions related to this trial
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neoplastic Processes
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Pathologic Processes
Interventions listed in this trial
investigational drug INGN 241
Sponsors listed in this trial
Introgen Therapeutics
M.D. Anderson Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services